The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
The global Paclitaxel market was valued at US$ 117.6 million in 2023 and is anticipated to reach US$ 205.5 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.
North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel.
Report Scope
The Paclitaxel market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paclitaxel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
The global Paclitaxel market was valued at US$ 117.6 million in 2023 and is anticipated to reach US$ 205.5 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.
North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel.
Report Scope
The Paclitaxel market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Paclitaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Paclitaxel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Paclitaxel Market Overview
1.1 Product Overview and Scope of Paclitaxel
1.2 Paclitaxel Segment by Type
1.2.1 Global Paclitaxel Market Value Comparison by Type (2024-2030)
1.2.2 Natural Paclitaxel API
1.2.3 Semi-synthetic Paclitaxel API
1.3 Paclitaxel Segment by Application
1.3.1 Global Paclitaxel Market Value by Application: (2024-2030)
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Global Paclitaxel Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel Revenue 2019-2030
1.4.2 Global Paclitaxel Sales 2019-2030
1.4.3 Global Paclitaxel Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Paclitaxel Market Competition by Manufacturers
2.1 Global Paclitaxel Sales Market Share by Manufacturers (2019-2024)
2.2 Global Paclitaxel Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Paclitaxel Average Price by Manufacturers (2019-2024)
2.4 Global Paclitaxel Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paclitaxel, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel, Product Type & Application
2.7 Paclitaxel Market Competitive Situation and Trends
2.7.1 Paclitaxel Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paclitaxel Players Market Share by Revenue
2.7.3 Global Paclitaxel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paclitaxel Retrospective Market Scenario by Region
3.1 Global Paclitaxel Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Paclitaxel Global Paclitaxel Sales by Region: 2019-2030
3.2.1 Global Paclitaxel Sales by Region: 2019-2024
3.2.2 Global Paclitaxel Sales by Region: 2025-2030
3.3 Global Paclitaxel Global Paclitaxel Revenue by Region: 2019-2030
3.3.1 Global Paclitaxel Revenue by Region: 2019-2024
3.3.2 Global Paclitaxel Revenue by Region: 2025-2030
3.4 North America Paclitaxel Market Facts & Figures by Country
3.4.1 North America Paclitaxel Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Paclitaxel Sales by Country (2019-2030)
3.4.3 North America Paclitaxel Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Paclitaxel Market Facts & Figures by Country
3.5.1 Europe Paclitaxel Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Paclitaxel Sales by Country (2019-2030)
3.5.3 Europe Paclitaxel Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel Market Facts & Figures by Country
3.6.1 Asia Pacific Paclitaxel Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Paclitaxel Sales by Country (2019-2030)
3.6.3 Asia Pacific Paclitaxel Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Paclitaxel Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Paclitaxel Sales by Country (2019-2030)
3.7.3 Latin America Paclitaxel Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paclitaxel Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Paclitaxel Sales by Country (2019-2030)
3.8.3 Middle East and Africa Paclitaxel Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Paclitaxel Sales by Type (2019-2030)
4.1.1 Global Paclitaxel Sales by Type (2019-2024)
4.1.2 Global Paclitaxel Sales by Type (2025-2030)
4.1.3 Global Paclitaxel Sales Market Share by Type (2019-2030)
4.2 Global Paclitaxel Revenue by Type (2019-2030)
4.2.1 Global Paclitaxel Revenue by Type (2019-2024)
4.2.2 Global Paclitaxel Revenue by Type (2025-2030)
4.2.3 Global Paclitaxel Revenue Market Share by Type (2019-2030)
4.3 Global Paclitaxel Price by Type (2019-2030)
5 Segment by Application
5.1 Global Paclitaxel Sales by Application (2019-2030)
5.1.1 Global Paclitaxel Sales by Application (2019-2024)
5.1.2 Global Paclitaxel Sales by Application (2025-2030)
5.1.3 Global Paclitaxel Sales Market Share by Application (2019-2030)
5.2 Global Paclitaxel Revenue by Application (2019-2030)
5.2.1 Global Paclitaxel Revenue by Application (2019-2024)
5.2.2 Global Paclitaxel Revenue by Application (2025-2030)
5.2.3 Global Paclitaxel Revenue Market Share by Application (2019-2030)
5.3 Global Paclitaxel Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Phyton
6.1.1 Phyton Corporation Information
6.1.2 Phyton Description and Business Overview
6.1.3 Phyton Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Phyton Paclitaxel Product Portfolio
6.1.5 Phyton Recent Developments/Updates
6.2 ScinoPharm
6.2.1 ScinoPharm Corporation Information
6.2.2 ScinoPharm Description and Business Overview
6.2.3 ScinoPharm Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ScinoPharm Paclitaxel Product Portfolio
6.2.5 ScinoPharm Recent Developments/Updates
6.3 Novasep
6.3.1 Novasep Corporation Information
6.3.2 Novasep Description and Business Overview
6.3.3 Novasep Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novasep Paclitaxel Product Portfolio
6.3.5 Novasep Recent Developments/Updates
6.4 Samyang
6.4.1 Samyang Corporation Information
6.4.2 Samyang Description and Business Overview
6.4.3 Samyang Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Samyang Paclitaxel Product Portfolio
6.4.5 Samyang Recent Developments/Updates
6.5 Polymed
6.5.1 Polymed Corporation Information
6.5.2 Polymed Description and Business Overview
6.5.3 Polymed Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Polymed Paclitaxel Product Portfolio
6.5.5 Polymed Recent Developments/Updates
6.6 TAPI (Teva)
6.6.1 TAPI (Teva) Corporation Information
6.6.2 TAPI (Teva) Description and Business Overview
6.6.3 TAPI (Teva) Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.6.4 TAPI (Teva) Paclitaxel Product Portfolio
6.6.5 TAPI (Teva) Recent Developments/Updates
6.7 Fresenius-kabi
6.6.1 Fresenius-kabi Corporation Information
6.6.2 Fresenius-kabi Description and Business Overview
6.6.3 Fresenius-kabi Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius-kabi Paclitaxel Product Portfolio
6.7.5 Fresenius-kabi Recent Developments/Updates
6.8 Huiang biopharma
6.8.1 Huiang biopharma Corporation Information
6.8.2 Huiang biopharma Description and Business Overview
6.8.3 Huiang biopharma Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Huiang biopharma Paclitaxel Product Portfolio
6.8.5 Huiang biopharma Recent Developments/Updates
6.9 Southpharma
6.9.1 Southpharma Corporation Information
6.9.2 Southpharma Description and Business Overview
6.9.3 Southpharma Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Southpharma Paclitaxel Product Portfolio
6.9.5 Southpharma Recent Developments/Updates
6.10 Yunnan Hande
6.10.1 Yunnan Hande Corporation Information
6.10.2 Yunnan Hande Description and Business Overview
6.10.3 Yunnan Hande Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Yunnan Hande Paclitaxel Product Portfolio
6.10.5 Yunnan Hande Recent Developments/Updates
6.11 Hainan Yew Pharm
6.11.1 Hainan Yew Pharm Corporation Information
6.11.2 Hainan Yew Pharm Paclitaxel Description and Business Overview
6.11.3 Hainan Yew Pharm Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hainan Yew Pharm Paclitaxel Product Portfolio
6.11.5 Hainan Yew Pharm Recent Developments/Updates
6.12 Jiangsu Yew Biotechnology
6.12.1 Jiangsu Yew Biotechnology Corporation Information
6.12.2 Jiangsu Yew Biotechnology Paclitaxel Description and Business Overview
6.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangsu Yew Biotechnology Paclitaxel Product Portfolio
6.12.5 Jiangsu Yew Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel Industry Chain Analysis
7.2 Paclitaxel Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel Production Mode & Process
7.4 Paclitaxel Sales and Marketing
7.4.1 Paclitaxel Sales Channels
7.4.2 Paclitaxel Distributors
7.5 Paclitaxel Customers
8 Paclitaxel Market Dynamics
8.1 Paclitaxel Industry Trends
8.2 Paclitaxel Market Drivers
8.3 Paclitaxel Market Challenges
8.4 Paclitaxel Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
